Ipsen: New Surveys Show Over 80% of Patients with Spasticity and Cervical Dystonia Treated with Botulinum Toxin-A Experience Debilitating Symptom Recurrence





Regulatory News:

Ipsen (Euronext: IPN; ADR: IPSEY) today presents the results of two......
. .
Veröffentlicht von: Finanzen.at - Nachrichten Ticker - 5 days ago
Share |